Dr. Mark Mckenna taking medical aesthetics to the masses

Dr. Mark Mckenna might not be a regular physician as he has more talents that meet the eye especially when it comes to building multimillion dollar businesses. It all started when studying at Tulane Medical School that he realized that it would be next to impossible to make a ton of money just by being a doctor.


After graduating back in the year 1999, Dr. Mark Mckenna went ahead and invested in real estate in New Orleans. But this was not to last as he was one of the victims of Hurricane Katrina which saw him lose millions overnight in the year 2005. The millions in losses did not stop him from pursuing his dream of becoming an entrepreneur which saw him dissolve his company. He then moved to Atlanta where he started ShapeMed. His new venture offered to provide laser hair removal, nutrition as well as Botox injections to the residents of that area.


In 2015, he was approached by Lifetime Fitness which is a publicly traded gym chain. Dr. Mark Mckenna saw this as an opportunity and grabbed it selling out and joining the company. He was given the position of a medical director of its Atlanta division, but it was short-lived. A year later, Dr. Mark Mckenna quit after two large private companies acquired the company. This led him towards a different direction which saw the creation of OVME which is based on combining medical aesthetics as well as technology to deliver services to its customers.

It will offer facial as well as skin services that will include injections that contain neurotoxins promoting healthy and youthful skin. These include the use of Dysport and Botox which have been tested and proven to be the efficient anti-aging components. Additionally, they will also be providing wellness as well as body services in the range of hormonal therapy. Such will aid in the fight against male baldness as well as hair loss. Ladies will also be treated to testosterone replacement services. The top of the cream will be the use of a patented remedy that will aid in weight management that conducts analysis using the individual’s DNA. Atlanta is going to be well placed to benefit from the years of experience that Dr. Mark Mckenna will offer them.



Lime Crime’s Heavenly New Eyeshadow Palettes

The cosmetics industry is loaded with brand after brand of makeup products. Some of the biggest names in the mainstream media comes from this specific line of work. This includes Revlon, Almay, Covergirl and Maybelline. On the other hand, when it comes to introducing fresh new products to the market, few companies can outshine Lime Crime. This affluent company has been around for only a decade, but it has reshaped the cosmetics environment. Lime Crime has just launched its all-new product, and it’s causing quite a stir. The all-new Venus 3 eyeshadow palette has captured the attention of the public thanks to its radiant finish.

Venus 3 is the next addition to the brand’s already successful line of eyeshadow palettes. With the success of the original Venus eyeshadow, the brand has been able to spawn other successful sequels. The Venus 2 and the Venus XL were very successful during their day, and they offer some of the most brilliant shades of rustic-finishes. This includes Aura (golden ivory), Muse (deep burgundy), Shell (opalescent-pink), Venus (bruised-fruit) and several others. On the other hand, the all-new Venus 3 eyeshadow palette mimics the soft radiant glow of the sky. These buttery-smooth finishes can easily be applied with a single swipe, and they are very long lasting. Lime Crime did a phenomenal job of teasing its millions of customers. The company has a knack for doing this, but it has turned-out to be a brilliant move. Venus 3 was released on April 24, 2018, and it is the next iteration of the brand’s popular eyeshadow finish.

These vibrant and lush pigments perfectly epitomizes Lime Crime’s essence. Venus 3 can be purchased for an estimated $38, and it is worth every cent. All in all, Lime Crime has continued to marvel the general public by changing the status quo and that’s a fact.